Averica Discovery Systems

Activities: Research & Development

Trending Articles

  1. Merck's MilliporeSigma cuts the ribbon on €290m US biosafety and analytical facility The site will host biosafety testing, analytical development and cell banking manufacturing services
  2. Johnson & Johnson completes V-Wave acquisition to support patients with heart failure The strategic acquisition will bolster the pharma giant's MedTech offerings for patients with cardiovascular disease
  3. Calluna Pharma appoints Mark Gaffney as CEO and Mark Altmeyer as Chair of the Board The two will work to advance the company's global presence, while developing its lead programme
  4. ABITEC Corporation bolsters its high-purity lipid offerings for LNP therapeutics The company can provide cGMP-grade lipids from a mg to a kg scale, assisting the production of advanced LNP therapeutics, including vaccines
  5. Roche's breast cancer combination therapy Itovebi bags FDA approval Itovebi plus palbociclib and fulvestrant reduced the risk of disease progression or death significantly in patients

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Ingredients

Averica expands pharmaceutical impurities services

Averica Discovery Services has expanded its service to include services such as nitrosamine and PFAS testing
Research & Development

Canadian-based Neopharm Labs completes acquisition of Boston-based Averica Discovery Services

The combined expertise creates a key player in the North American analytical market
Research & Development

Averica Discovery appoints Cynthia Berger as Vice President of Operations

Will contribute broadly to the firm's growth and development
Regulatory

Averica now able to handle Schedule I controlled substances

And expand the types of research that the company can support
Subscribe now